TickerFacts.

RenovoRx, Inc. (RNXT): Operating Income

Annual figures by period end, from SEC filings.

-$12.51M
Year ended 2025-12-31
-$13.54M
Trailing 12 months to 2026-06-30
2020-12-31: -$3.20M2021-12-31: -$5.67M2022-12-31: -$9.95M2023-12-31: -$11.40M2024-12-31: -$10.97M2025-12-31: -$12.51M-$12.51M
2020-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$12.51Mn/m2026-03-30, From 2025-01-01
2024-12-31-$10.97Mn/m2026-03-30, From 2024-01-01
2023-12-31-$11.40Mn/m2025-04-01, From 2023-01-01
2022-12-31-$9.95Mn/m2024-04-01, From 2022-01-01
2021-12-31-$5.67Mn/m2023-03-31, From 2021-01-01
2020-12-31-$3.20Mn/a2022-03-30, From 2020-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
RenovoRx, Inc. (RNXT)2025-12-31-$12.51Mn/m
PetVivo Holdings, Inc. (PETV)2026-03-31-$9.06Mn/m
SeaStar Medical Holding Corp (ICU)2025-12-31-$12.18Mn/m
Sintx Technologies, Inc. (SINT)2025-12-31-$10.72Mn/m
Catheter Precision, Inc. (VTAK)2025-12-31-$21.14Mn/m
EBR Systems, Inc. (NONE.)2025-12-31-$46.09Mn/m
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31-$6.92Mn/m
Vycor Medical Inc (VYCO)2025-12-31$33.9Kn/m
Co-Diagnostics, Inc. (CODX)2025-12-31-$50.17Mn/m

Compare RNXT, PETV, ICU, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗